Contact, publication, and social network information about Harvard faculty and fellows. Harvard Catalyst Profiles
Keywords
Last Name
Institution

Akila Ninette Viswanathan, M.D.

TitleAssociate Professor of Radiation Oncology
InstitutionBrigham and Women's Hospital
DepartmentRadiation Oncology
AddressBrigham and Women's Hospital
Radiation Oncology, L2
75 Francis St
Boston MA 02115
Phone617/632-7325
Fax617/278-6988

 Bibliographic 
 selected publications
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
List All   |   Timeline
  1. Han K, Milosevic M, Fyles A, Viswanathan AN. In reply to smith and eifel. Int J Radiat Oncol Biol Phys. 2014 Feb 1; 88(2):460-1.
    View in: PubMed
  2. Golden DW, Spektor A, Rudra S, Ranck MC, Krishnan MS, Jimenez RB, Viswanathan AN, Koshy M, Howard AR, Chmura SJ. Radiation Oncology Medical Student Clerkship: Implementation and Evaluation of a Bi-institutional Pilot Curriculum. Int J Radiat Oncol Biol Phys. 2014 Jan 1; 88(1):45-50.
    View in: PubMed
  3. Lee LJ, Demaria R, Berkowitz R, Matulonis U, Viswanathan AN. Clinical predictors of long-term survival for stage IVB uterine papillary serous carcinoma confined to the abdomen. Gynecol Oncol. 2014 Jan; 132(1):65-9.
    View in: PubMed
  4. Viswanathan AN, Lee H, Berkowitz R, Berlin S, Campos S, Feltmate C, Horowitz N, Muto M, Sadow CA, Matulonis U. A prospective feasibility study of radiation and concurrent bevacizumab for recurrent endometrial cancer. Gynecol Oncol. 2014 Jan; 132(1):55-60.
    View in: PubMed
  5. Damato AL, Cormack RA, Viswanathan AN. Characterization of implant displacement and deformation in gynecologic interstitial brachytherapy. Brachytherapy. 2014 Jan-Feb; 13(1):100-9.
    View in: PubMed
  6. Viswanathan AN, Damato AL, Nguyen PL. Novel use of a hydrogel spacer permits reirradiation in otherwise incurable recurrent gynecologic cancers. J Clin Oncol. 2013 Dec 1; 31(34):e446-7.
    View in: PubMed
  7. Damato AL, Viswanathan AN, Cormack RA. Validation of mathematical models for the prediction of organs-at-risk dosimetric metrics in high-dose-rate gynecologic interstitial brachytherapy. Med Phys. 2013 Oct; 40(10):101711.
    View in: PubMed
  8. Buyyounouski MK, Viswanathan AN, Prestidge BR. Examining the evidence in pursuit of the highest possible brachytherapy standards. Brachytherapy. 2014 Jan-Feb; 13(1):15-6.
    View in: PubMed
  9. Lee LJ, Damato AL, Viswanathan AN. Clinical outcomes following 3D image-guided brachytherapy for vaginal recurrence of endometrial cancer. Gynecol Oncol. 2013 Dec; 131(3):586-92.
    View in: PubMed
  10. Han K, Milosevic M, Fyles A, Pintilie M, Viswanathan AN. Trends in the utilization of brachytherapy in cervical cancer in the United States. Int J Radiat Oncol Biol Phys. 2013 Sep 1; 87(1):111-9.
    View in: PubMed
  11. Miyamoto DT, Viswanathan AN. Concurrent chemoradiation for vaginal cancer. PLoS One. 2013; 8(6):e65048.
    View in: PubMed
  12. Viswanathan AN, Pinto AP, Schultz D, Berkowitz R, Crum CP. Relationship of margin status and radiation dose to recurrence in post-operative vulvar carcinoma. Gynecol Oncol. 2013 Sep; 130(3):545-9.
    View in: PubMed
  13. Lee LJ, Damato AL, Viswanathan AN. Clinical outcomes of high-dose-rate interstitial gynecologic brachytherapy using real-time CT guidance. Brachytherapy. 2013 Jul-Aug; 12(4):303-10.
    View in: PubMed
  14. Viswanathan AN, Szymonifka J, Tempany-Afdhal CM, O'Farrell DA, Cormack RA. A prospective trial of real-time magnetic resonance-guided catheter placement in interstitial gynecologic brachytherapy. Brachytherapy. 2013 May-Jun; 12(3):240-7.
    View in: PubMed
  15. Townamchai K, Berkowitz R, Bhagwat M, Damato AL, Friesen S, Lee LJ, Matulonis U, O'Farrell D, Viswanathan AN. Vaginal brachytherapy for early stage uterine papillary serous and clear cell endometrial cancer. Gynecol Oncol. 2013 Apr; 129(1):18-21.
    View in: PubMed
  16. Poorvu PD, Sadow CA, Townamchai K, Damato AL, Viswanathan AN. Duodenal and other gastrointestinal toxicity in cervical and endometrial cancer treated with extended-field intensity modulated radiation therapy to paraaortic lymph nodes. Int J Radiat Oncol Biol Phys. 2013 Apr 1; 85(5):1262-8.
    View in: PubMed
  17. Kapur T, Egger J, Damato A, Schmidt EJ, Viswanathan AN. 3-T MR-guided brachytherapy for gynecologic malignancies. Magn Reson Imaging. 2012 Nov; 30(9):1279-90.
    View in: PubMed
  18. Townamchai K, Lee L, Viswanathan AN. A novel low dose fractionation regimen for adjuvant vaginal brachytherapy in early stage endometrioid endometrial cancer. Gynecol Oncol. 2012 Nov; 127(2):351-5.
    View in: PubMed
  19. Lee LJ, Viswanathan AN. Combined chemotherapy and radiation improves survival for node-positive endometrial cancer. Gynecol Oncol. 2012 Oct; 127(1):32-7.
    View in: PubMed
  20. Lee LJ, Viswanathan AN. Predictors of Toxicity After Image-guided High-dose-rate Interstitial Brachytherapy for Gynecologic Cancer. Int J Radiat Oncol Biol Phys. 2012 Dec 1; 84(5):1192-7.
    View in: PubMed
  21. Gay HA, Barthold HJ, O'Meara E, Bosch WR, El Naqa I, Al-Lozi R, Rosenthal SA, Lawton C, Lee WR, Sandler H, Zietman A, Myerson R, Dawson LA, Willett C, Kachnic LA, Jhingran A, Portelance L, Ryu J, Small W, Gaffney D, Viswanathan AN, Michalski JM. Pelvic normal tissue contouring guidelines for radiation therapy: a Radiation Therapy Oncology Group consensus panel atlas. Int J Radiat Oncol Biol Phys. 2012 Jul 1; 83(3):e353-62.
    View in: PubMed
  22. Viswanathan AN, Beriwal S, De Los Santos JF, Demanes DJ, Gaffney D, Hansen J, Jones E, Kirisits C, Thomadsen B, Erickson B. American Brachytherapy Society consensus guidelines for locally advanced carcinoma of the cervix. Part II: high-dose-rate brachytherapy. Brachytherapy. 2012 Jan-Feb; 11(1):47-52.
    View in: PubMed
  23. Lee LJ, Das IJ, Higgins SA, Jhingran A, Small W, Thomadsen B, Viswanathan AN, Wolfson A, Eifel P. American Brachytherapy Society consensus guidelines for locally advanced carcinoma of the cervix. Part III: low-dose-rate and pulsed-dose-rate brachytherapy. Brachytherapy. 2012 Jan-Feb; 11(1):53-7.
    View in: PubMed
  24. Viswanathan AN, Moughan J, Small W, Levenback C, Iyer R, Hymes S, Dicker AP, Miller B, Erickson B, Gaffney DK. The quality of cervical cancer brachytherapy implantation and the impact on local recurrence and disease-free survival in radiation therapy oncology group prospective trials 0116 and 0128. Int J Gynecol Cancer. 2012 Jan; 22(1):123-31.
    View in: PubMed
  25. Viswanathan AN, Thomadsen B. American Brachytherapy Society consensus guidelines for locally advanced carcinoma of the cervix. Part I: general principles. Brachytherapy. 2012 Jan-Feb; 11(1):33-46.
    View in: PubMed
  26. Small W, Beriwal S, Demanes DJ, Dusenbery KE, Eifel P, Erickson B, Jones E, Rownd JJ, De Los Santos JF, Viswanathan AN, Gaffney D. American Brachytherapy Society consensus guidelines for adjuvant vaginal cuff brachytherapy after hysterectomy. Brachytherapy. 2012 Jan-Feb; 11(1):58-67.
    View in: PubMed
  27. Beriwal S, Demanes DJ, Erickson B, Jones E, De Los Santos JF, Cormack RA, Yashar C, Rownd JJ, Viswanathan AN. American Brachytherapy Society consensus guidelines for interstitial brachytherapy for vaginal cancer. Brachytherapy. 2012 Jan-Feb; 11(1):68-75.
    View in: PubMed
  28. Viswanathan AN. Advances in the use of radiation for gynecologic cancers. Hematol Oncol Clin North Am. 2012 Feb; 26(1):157-68.
    View in: PubMed
  29. Viswanathan AN, Macklin EA, Berkowitz R, Matulonis U. The importance of chemotherapy and radiation in uterine papillary serous carcinoma. Gynecol Oncol. 2011 Dec; 123(3):542-7.
    View in: PubMed
  30. Holloway CL, Macklin EA, Cormack RA, Viswanathan AN. Should the organs at risk be contoured in vaginal cuff brachytherapy? Brachytherapy. 2011 Jul-Aug; 10(4):313-7.
    View in: PubMed
  31. Viswanathan AN, Creutzberg CL, Craighead P, McCormack M, Toita T, Narayan K, Reed N, Long H, Kim HJ, Marth C, Lindegaard JC, Cerrotta A, Small W, Trimble E. International brachytherapy practice patterns: a survey of the Gynecologic Cancer Intergroup (GCIG). Int J Radiat Oncol Biol Phys. 2012 Jan 1; 82(1):250-5.
    View in: PubMed
  32. Mak RH, Halasz LM, Tanaka CK, Ancukiewicz M, Schultz DJ, Russell AH, Viswanathan AN. Outcomes after radiation therapy with concurrent weekly platinum-based chemotherapy or every-3-4-week 5-fluorouracil-containing regimens for squamous cell carcinoma of the vulva. Gynecol Oncol. 2011 Jan; 120(1):101-7.
    View in: PubMed
  33. Viswanathan AN. Childhood cancer survivors: stillbirth and neonatal death. Lancet. 2010 Aug 21; 376(9741):570-2.
    View in: PubMed
  34. Lim K, Small W, Portelance L, Creutzberg C, Jürgenliemk-Schulz IM, Mundt A, Mell LK, Mayr N, Viswanathan A, Jhingran A, Erickson B, De los Santos J, Gaffney D, Yashar C, Beriwal S, Wolfson A, Taylor A, Bosch W, El Naqa I, Fyles A. Consensus guidelines for delineation of clinical target volume for intensity-modulated pelvic radiotherapy for the definitive treatment of cervix cancer. Int J Radiat Oncol Biol Phys. 2011 Feb 1; 79(2):348-55.
    View in: PubMed
  35. Viswanathan AN, Yorke ED, Marks LB, Eifel PJ, Shipley WU. Radiation dose-volume effects of the urinary bladder. Int J Radiat Oncol Biol Phys. 2010 Mar 1; 76(3 Suppl):S116-22.
    View in: PubMed
  36. Viswanathan AN, Thomadsen B. ASTRO/ABS National Gidlines for Gynecologic Brachytherapy. Int J Radiat Onc Biol Phys. 2010.
  37. Chang MC, Nevadunsky NS, Viswanathan AN, Crum CP, Feltmate CM. Endocervical adenocarcinoma in situ with ovarian metastases: a unique variant with potential for long-term survival. Int J Gynecol Pathol. 2010 Jan; 29(1):88-92.
    View in: PubMed
  38. Viswanathan AN, Erickson BA. Three-dimensional imaging in gynecologic brachytherapy: a survey of the American Brachytherapy Society. Int J Radiat Oncol Biol Phys. 2010 Jan 1; 76(1):104-9.
    View in: PubMed
  39. Viswanathan AN, Cormack R, Rawal B, Lee H. Increasing brachytherapy dose predicts survival for interstitial and tandem-based radiation for stage IIIB cervical cancer. Int J Gynecol Cancer. 2009 Nov; 19(8):1402-6.
    View in: PubMed
  40. Holloway CL, Racine ML, Cormack RA, O'Farrell DA, Viswanathan AN. Sigmoid dose using 3D imaging in cervical-cancer brachytherapy. Radiother Oncol. 2009 Nov; 93(2):307-10.
    View in: PubMed
  41. Lin MC, Burkholder KA, Viswanathan AN, Neuberg D, Mutter GL. Involution of latent endometrial precancers by hormonal and nonhormonal mechanisms. Cancer. 2009 May 15; 115(10):2111-8.
    View in: PubMed
  42. Wo JY, Viswanathan AN. Impact of radiotherapy on fertility, pregnancy, and neonatal outcomes in female cancer patients. Int J Radiat Oncol Biol Phys. 2009 Apr 1; 73(5):1304-12.
    View in: PubMed
  43. Wo J, Viswanathan AN. The Impace of Radiotherapy on Fertility, Pregnancy and Neonatal Outcomes of Female Cancer Patients. Int J Radiat Oncol Biol Phys. 2009; 69(3):963-4.
  44. Lee LJ, Sadow CA, Russell A, Viswanathan AN. Correlation of point B and lymph node dose in 3D-planned high-dose-rate cervical cancer brachytherapy. Int J Radiat Oncol Biol Phys. 2009 Nov 1; 75(3):803-9.
    View in: PubMed
  45. Lee L, Viswanathan AN. . Prognostic Value of Lymph Node Ratio for Uterine Papillary Serous Cancer. (Submitted ASTRO 2009). 2009.
  46. Viswanathan AN, Erickson B. Interstitial Brachytherapy: the Role of 3D Image-Guided Gynaecologic Radiation. Viswanathan AN, Erickson B, Potter R, Kirisits C, eds. Gynecologic Radiation Therapy: Novel Approaches to Image Guidance and Management. 2009; anticipated.
  47. Viswanathan AN, Hanwen J, Cormack RA. Image-Guided Cervical Cancer Brachytherapy: The Brigham and Women's/Dana-Farber Experience. Viswanathan An, Erickson B, Potter R, Kirisits C, eds. Gynecologic Radiation Therapy: Novel Pproaches to Image-Guidance and Management. 2009; anticipated.
  48. Viswanathan AN, Marks L, Yorkee E, Eifel PJ, Shipley WU. Radiation-Associated Bladder Injury. Inf J Radiat Oncol Biol Phys. 2009.
  49. Racine ML, Holloway CL, Cormack RA, O'Farrell DA, Viswanathan AN. Dosimetric Analysis of 3D Image-Guided cervical Cancer Low-dose-rate Tandem and Ovoid and Interstitial Brachytherapy. Brachytherapy. 2009; accepted.
  50. Viswanathan AN. Maintenance of Certification Self-Assessment Modules (SAMs). 2009.
  51. Viswanathan A et al. . RTOG 0116/0128 Quality of Brachytherapy Implants . (Submitted ASTRO 2009). 2009.
  52. Holloway CL, Racine ML, Cormack RA, O'Farrell DA, Viswanathan AN. Sigmoid dose Using 3D Imaging in Cervial Cancer Brachytherapy. Radiotherapy and Oncology. 2009; accepted.
  53. Viswanathan A, Erickson B, Dirisits C, Poetter R, eds. Gynecologic Radiation Therapy: Novel Approaches to Image-Guidance and Management. 2009.
  54. Mak R, Viswanathan AN, Shipley WS. The urinary bladder: late effects following pelvic irradiation. Challenges of Interstitial Brachytherapy: the Role of 3D Image-Guided Gynaecologic Radiation. Rubin P, Constine LS, Marks LB, Williams JP and Hansen JT, eds. ALERT Adverse Late Effects of Cancer Treatment. 2009.
  55. Mak R, Halasz, L, Russell AH, Viswanathan AN. . Chemoradiation for Vulvar cancer. (Submitted ASTRO 2009) . 2009.
  56. Viswanathan AN, Schernhammer ES. Circulating melatonin and the risk of breast and endometrial cancer in women. Cancer Lett. 2009 Aug 18; 281(1):1-7.
    View in: PubMed
  57. Stewart AJ, Cormack RA, Lee H, Xiong L, Hansen JL, O'Farrell DA, Viswanathan AN. Prospective clinical trial of bladder filling and three-dimensional dosimetry in high-dose-rate vaginal cuff brachytherapy. Int J Radiat Oncol Biol Phys. 2008 Nov 1; 72(3):843-8.
    View in: PubMed
  58. Viswanathan AN, Feskanich D, Schernhammer ES, Hankinson SE. Aspirin, NSAID, and acetaminophen use and the risk of endometrial cancer. Cancer Res. 2008 Apr 1; 68(7):2507-13.
    View in: PubMed
  59. Haglund KE, Viswanathan AN. Computed tomography-based radiation therapy of ovarian remnants for symptomatic persistent endometriosis. Obstet Gynecol. 2008 Feb; 111(2 Pt 2):579-83.
    View in: PubMed
  60. Viswanathan AN. The Frank Ellis memorial lecture: the use of three-dimensional imaging in gynaecological radiation therapy. Clin Oncol (R Coll Radiol). 2008 Feb; 20(1):1-5.
    View in: PubMed
  61. Viswanathan AN, Buttin BM, Kennedy AM. Oncodiagnosis Panel: 2006. Ovarian, cervical, and endometrial cancer. Radiographics. 2008 Jan-Feb; 28(1):289-307.
    View in: PubMed
  62. Viswanathan AN. The Frank Ellis Memorial Lecture: Image-Guided gynecologic Radiation Therapy. Clin Oncol. 2008; 20:1-5.
  63. Racine ML, O’Farrell DA, Cormack RA, Viswanathan AN . 4Gy versus 6 Gy fraction for cylinder brachytherapy. Poster Presentation, ASTRO Annual Meeting. 2008.
  64. Lee L, Viswanathan AN. . Stage IIIC endometrial carcinoma. ASTRO annual meeting poster. 2008.
  65. Holloway CL, Macklin EA, Cormack RA, Viswanathan, AN . Should The Organs At Risk Be Contoured In Vaginal Cuff Brachytherapy? An Analysis Of Within-Patient Variance. Poster Presentation, ABS Annual Meeting . 2008.
  66. Viswanathan AN. Management of Rare subtypes of Cervical Cancer. Jhingran A,k Levenback C, eds. Biology and Management of Cervical Carcinoma. 2008.
  67. Wilson JA, Viswanathan AN. Course of Care. Enterprice Imaging and Therapeutic Radiology Management. 2008; (Jan):29-32.
  68. Viswanathan AN, Buttin B, Kennedy AR. Oncodiagnosis Panel: 2006 Gynecologic Malignancies: diagnosis and Treatment. Radiographics. 2008; 28(1):289-308.
  69. Wo J, Crum C, Viswanathan AN. . Vulvar cancer and margin status. ASTRO annual meeting oral presentation . 2008.
  70. Viswanathan AN, Tanaka C. . Vulvar PET imaging. Poster at ASTRO Annual Meeting. 2008.
  71. Racine ML, Holloway CL, O’Farrell D, Cormack RA, Viswanathan AN . Image guided brachytherapy for gynecological malignancies: comparison of rectal and sigmoid dose using LDR interstitial implant versus tandem and ovoids. Accepted Poster Presentation, ABS Annual Meeting. 2008.
  72. Viswanathan AN, Buttin B, Kennedy AR. Ocodiagnosis Panel: 2006 Gynecologic Malignancies: Diagnosis and Treatment. Radiographics. 2007.
  73. Viswanathan AN, Hankinson SE, Schernhammer ES. Night shift work and the risk of endometrial cancer. Cancer Res. 2007 Nov 1; 67(21):10618-22.
    View in: PubMed
  74. Viswanathan AN, Dimopoulos J, Kirisits C, Berger D, Pötter R. Computed tomography versus magnetic resonance imaging-based contouring in cervical cancer brachytherapy: results of a prospective trial and preliminary guidelines for standardized contours. Int J Radiat Oncol Biol Phys. 2007 Jun 1; 68(2):491-8.
    View in: PubMed
  75. Holloway CH, Viswanathan AN. Brachytherapy. Cancer Enzyclopedia. 2007; (accepted).
  76. Viswanathan AN. Challenges of Interstitial Brachytherapy: the Role of 3 Image-Guided Gynaecologic Radiation. Mould R, ed. Choices in Advanced Radiotherapy. 2007.
  77. Viswanathan AN, Campos S, Matulonis U, Berkowitz R . Chemotherapy and radiation therapy in uterine papillary serous carcinoma. ASCO poster presentation. 2007.
  78. Holloway CL, Russell AH, Muto M, Albert M, Viswanathan AN. Synovial cell sarcoma of the vulva: multimodality treatment incorporating preoperative external-beam radiation, hemivulvectomy, flap reconstruction, interstitial brachytherapy, and chemotherapy. Gynecol Oncol. 2007 Jan; 104(1):253-6.
    View in: PubMed
  79. Stewart AJ, Viswanathan AN. Current controversies in high-dose-rate versus low-dose-rate brachytherapy for cervical cancer. Cancer. 2006 Sep 1; 107(5):908-15.
    View in: PubMed
  80. Viswanathan AN, Cormack R, Holloway CL, Tanaka C, O'Farrell D, Devlin PM, Tempany C. Magnetic resonance-guided interstitial therapy for vaginal recurrence of endometrial cancer. Int J Radiat Oncol Biol Phys. 2006 Sep 1; 66(1):91-9.
    View in: PubMed
  81. Doctors Using Radiation-Filled Needles On Tumors http://cbs4boston.com/mallika/local_story_181152624.html . 2006.
  82. Viswanathan AN, Lee H, Hanson E, Berkowitz RS, Crum CP. Influence of margin status and radiation on recurrence after radical hysterectomy in Stage IB cervical cancer. Int J Radiat Oncol Biol Phys. 2006 Aug 1; 65(5):1501-7.
    View in: PubMed
  83. Xiong L, Viswanathan A, Stewart AJ, Haker S, Tempany CM, Chin LM, Cormack RA. Deformable structure registration of bladder through surface mapping. Med Phys. 2006 Jun; 33(6):1848-56.
    View in: PubMed
  84. Viswanathan AN, Schernhammer E, Feskanich D, Devivo I, colditz G, Hunter D, Hankinson S. Aspirin use and the risk of endometrial cancer. 2006; in preparation.
  85. Stewart AJ and Viswanathan AN. Current controversies in brachytherapy in cervical cancer. Cancer. 2006; (accepted).
  86. Holloway CL, Xiong L, Cormack, RA, Viswanathan, AN. 3D Analysis of Dose to the Bladder, Sigmoid, and Rectum in Vaginal cylinder Brachytherapy. Poster, ASTRO Annual Meeting, Philadelphia, PA. 2006.
  87. Viswanathan AN. Endometrial Cancer Chemoprevention Intrauterine Device. 2006.
  88. Holloway CL, O'Farrell D, Cormack RA, viswanathan, AN. Sigmoid dose delivered by high dose rate brachytherapy versus low dose rate brachytherapy in cervical cancer. ASTRO Annual Meeting, Philadelphia, PA. 2006.
  89. Holloway CL, Kirisits C, Cormack RA, Viswanathan, AN. . Comparison of the vaginal dose delivered by tandem and ovoid versus tandem and ring in cervical cancer. Oral Presentation, ABS Annual Meeting, Philadelphia, PA. 2006.
  90. Viswanathan AN, Petereit D. Gynecologic Brachytherapy. Devlin P, editor. Brachytherapy - Applications and Techniques. 2006.
  91. Viswanathan AN. Endometrial brachytherapy with MR allows for more targeted treatment. 2005.
  92. Viswanathan AN, Feskanich D, De Vivo I, Hunter DJ, Barbieri RL, Rosner B, Colditz GA, Hankinson SE. Smoking and the risk of endometrial cancer: results from the Nurses' Health Study. Int J Cancer. 2005 May 10; 114(6):996-1001.
    View in: PubMed
  93. Stewart AJ, Cormack RA, Xiong L, Hang L, Hansen JL, Devlin PM, Viswanthan AN. Bladder Dosimetry in High Dose Rate Vaginal Cuff Brachytherapy. Poster Presentation. 2005.
  94. Viswanathan AN. Website content, Gynecologic Oncology, Radiation Section. http://www.dana-farber.org/pat/adult/gynecologic-cancer/patient-information/radiation.html. 2005.
  95. Viswanathan AN and Russell AR. Partners Health Care System Treatment Guidelines for Endometrial Cancer. 2005.
  96. Viswanathan AN, Deavers MT, Jhingran A, Ramirez PT, Levenback C, Eifel PJ. Small cell neuroendocrine carcinoma of the cervix: outcome and patterns of recurrence. Gynecol Oncol. 2004 Apr; 93(1):27-33.
    View in: PubMed
  97. Viswanathan AN, Grier HE, Litman HJ, Perez-Atayde A, Tarbell NJ, Neuberg D, Shamberger RC, Marcus KJ. Outcome for children with group III rhabdomyosarcoma treated with or without radiotherapy. Int J Radiat Oncol Biol Phys. 2004 Mar 15; 58(4):1208-14.
    View in: PubMed
  98. Viswanathan AN, Feskanich D, Devivo I, Rosner B, Colditz G, Hunter D, Hankinson S. Aspirin use and the risk of Endometrial Cancer. Proceedings of the Society of Gynecologic Oncology. 2004; 187(139).
  99. Viswanathan AN. Medical Student radiation oncology rotation manual including course information, articles and lectures. 2003.
  100. Cutler C, Giri S, Jeyapalan S, Paniagua D, Viswanathan A, Antin JH. Acute and chronic graft-versus-host disease after allogeneic peripheral-blood stem-cell and bone marrow transplantation: a meta-analysis. J Clin Oncol. 2001 Aug 15; 19(16):3685-91.
    View in: PubMed
  101. Arbiser JL, Karalis K, Viswanathan A, Koike C, Anand-Apte B, Flynn E, Zetter B, Majzoub JA. Corticotropin-releasing hormone stimulates angiogenesis and epithelial tumor growth in the skin. J Invest Dermatol. 1999 Nov; 113(5):838-42.
    View in: PubMed
  102. Anand-Apte B, Zetter BR, Viswanathan A, Qiu RG, Chen J, Ruggieri R, Symons M. Platelet-derived growth factor and fibronectin-stimulated migration are differentially regulated by the Rac and extracellular signal-regulated kinase pathways. J Biol Chem. 1997 Dec 5; 272(49):30688-92.
    View in: PubMed
  103. Viswanathan AN. “Sequence Evoluation of the Mitochondrial DNA D Loop Region in Chimpanzees: A Study of Genetic Variability in Pan Troglodytes Subspecies”. 1991.
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact Human Resources at faculty_serviceshms.harvard.edu.
Viswanathan's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts
_
Co-Authors
_
Similar People
_
Same Department
Physical Neighbors
_